The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Glutamatergic Changes with Treatment in Attention Deficit Hyperactivity Disorder: A Preliminary Case Series
Abstract
Magnetic resonance spectroscopy, a noninvasive neuroimaging method, is a technique with the potential to measure in vivo neurochemical changes to different medication treatments. Symptoms of attention deficit hyperactivity disorder (ADHD) improved in two children treated with methylphenidate and two children treated with atomoxetine, for whom pre- and posttreatment proton magnetic resonance spectroscopy examinations were obtained to assess the relation between the neurochemical profiles in the striatum and prefrontal cortex among symptom severity and response to treatment. In the striatum, a striking decrease in the glutamate/creatine ratio (mean change 56.1%) was observed between 14 and 18 weeks of therapy in all four children with ADHD. In the prefrontal cortex, however, changes in the glutamate/creatine ratio were noted only in subjects receiving atomoxetine, not in those receiving methylphenidate. These data suggest that in vivo magnetic resonance spectroscopy measurement has the potential to assess response to psychopharmacological treatment in children with ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results of the few studies that have examined the effect of stimulants on left PFC glutamate levels are inconsistent and have shown that stimulants either decrease (Wiguna et al, 2012) or have no effect (Carrey et al, 2002; Husarova et al, 2014b) on glutamate concentrations.”
From Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties (2017) · cites this paper as Carrey et al, 2002
Citations
Cites
Models of Information Processing in the Basal Ganglia
(1994) · doi:10.7551/mitpress/4708.001.0001 · Cited by 1,190
Electrical Stimulation of the Medial Prefrontal Cortex Increases Dopamine Release in the Striatum
Taber, M. T., & Fibiger, H. C. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.63 · Cited by 99
Research works printed but not linked: 10
- 10.1016/S0006-3223(01)01321-X · DOI
- 10.1542/peds.108.5.e83 · DOI · Paper page
- 10.1097/00004583-199603000-00006 · DOI
- 10.1016/S0006-3223(97)00443-5 · DOI · Paper page
- 10.1097/00004583-200009000-00008 · DOI · Paper page
- 10.1176/appi.ajp.158.1.11 · DOI
- 10.1016/S0166-4328(97)00175-7 · DOI · Paper page
- Taber MT, 1995, J Neurosci, 15, 3896, 10.1523/JNEUROSCI.15-05-03896.1995 · DOI
- 10.1002/(SICI)1098-2396(199803)28:3<220::AID-SYN5>3.3.CO;2-C · DOI
- Vitiello B, 2001, CMAJ, 165, 1505
Cited by
Sorted by citations
Bush, G., Valera, E. M., & Seidman, L. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.034 · Cited by 714
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial
ARNOLD, L. E., AMAN, M. G., COOK, A. M., WITWER, A. N., HALL, K. L., THOMPSON, S., & RAMADAN, Y. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000231976.28719.2a · Cited by 260
Non?stimulant medications in the treatment of ADHD
Banaschewski, T., Roessner, V., Dittmann, R. W., Janardhanan Santosh, P., & Rothenberger, A. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1010-x · Cited by 183
Striatal Creatine and Glutamate/Glutamine in Attention-Deficit/Hyperactivity Disorder
Carrey, N. J., MacMaster, F. P., Gaudet, L., & Schmidt, M. H. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0008 · Cited by 117
Self-citationNaaijen, J., Lythgoe, D. J., Amiri, H., Buitelaar, J. K., & Glennon, J. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.009 · Cited by 117
Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism
Kim, J.-W., Seung, H., Kim, K. C., Gonzales, E. L. T., Oh, H. A., Yang, S. M., Ko, M. J., Han, S.-H., Banerjee, S., & Shin, C. Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.014 · Cited by 102
Shanmugan, S., Loughead, J., Nanga, R. P. R., Elliott, M., Hariharan, H., Appleby, D., Kim, D., Ruparel, K., Reddy, R., Brown, T. E., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.162 · Cited by 33
Metadata
- Authors
- Carrey, N., MacMaster, F. P., Sparkes, S. J., Khan, S. C., & Kusumakar, V.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2002-12
- Volume
- 12
- Issue
- 4
- Pages
- 331-336
- ISSN
- 1044-5463
- 1557-8992
- Cited by
- 49
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
